-+ 0.00%
-+ 0.00%
-+ 0.00%

Citi Trims Nahdi Medical's PT, Maintains Buy Rating

MT Newswires·08/06/2026 08:31:04
Listen to the news
08:31 AM EDT, 08/06/2026 (MT Newswires) -- Citi on Thursday lowered the price target for retail pharmacy and healthcare company Nahdi Medical (SASE:4164) to 115.00 Saudi riyals from 120.00 riyals and reiterated its buy rating. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)